Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | V218del |
Impact List | deletion |
Protein Effect | unknown |
Gene Variant Descriptions | TP53 V218del results in the deletion of one amino acid within the DNA-binding domain of the Tp53 protein (PMID: 21760703). V218del has been identified in the scientific literature (PMID: 31892709), but has not been biochemically characterized and therefore, its effect on Tp53 protein function is unknown (PubMed, Feb 2024). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon6 TP53 V218del |
Transcript | NM_000546.6 |
gDNA | chr17:g.7674883_7674885delCAC |
cDNA | c.652_654delGTG |
Protein | p.V218delV |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001407269.1 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001407271.1 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001276760.3 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218del | RefSeq | GRCh38/hg38 |
NM_001276695.3 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001276696.3 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001126118.2 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_001126115.2 | chr17:g.7670659_7670661delGAG | c.652_654delCTC | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_001407265.1 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_001407267.1 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001276697.3 | chr17:g.7669660_7669662delGGT | c.652_654delACC | p.T218delT | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.7674883_7674885delCAC | c.652_654delGTG | p.V218delV | RefSeq | GRCh38/hg38 |
NM_001407263.1 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
NM_001276761.3 | chr17:g.7674192_7674194delCAG | c.652_654delCTG | p.L218delL | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|